Dexmedetomidine Protects Against Kidney Fibrosis in Diabetic Mice by Targeting miR-101-3p-Mediated EndMT

Objective: Our main purpose is to explore the effect and mechanism of Dexmedetomidine (DEX)  in diabetic nephropathy fibrosis. Methods: Diabetic model was established by intraperitoneal injection of streptozotocin (STZ) treated CD-1 mice and high glucose cultured human dermal microvascular endotheli...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Li, Feng, Songlin, Yu, Hao, Shi, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973067/
https://www.ncbi.nlm.nih.gov/pubmed/35370507
http://dx.doi.org/10.1177/15593258221083486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973067/
https://www.ncbi.nlm.nih.gov/pubmed/35370507
http://dx.doi.org/10.1177/15593258221083486

Ejemplares similares